Cytomab 100 mg Injection
  1. Home
  2. Pharma Products
  3. Alkem Laboratories Ltd
  4. Cytomab 100 mg Injection

Cytomab 100 mg Injection

Cytomab 100 mg Injection contains rituximab, a monoclonal antibody medicine used for certain blood cancers and immune-related conditions. It is supplied as a 100 mg/10 mL formulation for intravenous infusion. The medicine targets CD20-positive B cells and is administered under qualified medical supervision.

BUY NOW

Category

Rituximab binds to the CD20 antigen present on certain B lymphocytes and helps reduce abnormal B-cell activity. Cytomab 100 mg Injection may be used in treatment protocols for non-Hodgkin lymphoma and chronic lymphocytic leukemia, as well as selected autoimmune conditions. The dose and infusion schedule depend on the condition being treated and the prescribed clinical protocol. Treatment should be administered and monitored by qualified healthcare professionals in an appropriate medical setting.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 100 mg
Concentration 100 mg/10 mL
Dosage Form Solution for Infusion
Route of Administration Intravenous Infusion
Pack Size 1 Vial of 10 mL

Product Also Known As

Cytomab 100 mg Injection, Rituximab 100 mg Injection, Rituximab 100 mg/10 mL Injection, Cytomab Rituximab Infusion, Anti-CD20 Monoclonal Antibody Injection, Rituximab Cancer Treatment Injection